Evidence map›Paper›PMID 26173894›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2016

Accurate analysis and visualization of cardiac (11)C-PIB uptake in amyloidosis with semiautomatic software.

Tanja Kero, Lars Lindsjö, Jens Sörensen, Mark Lubberink

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. The flutemetamol analogue cyano-flutemetamol detects myocardial AL and ATTR amyloid deposits: a post-mortem histofluorescence analysis.Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis · 2023
    Article
  2. Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden UsingJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  3. Article
  4. Article
  5. Review
  6. Quantification ofJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020
    Article
  7. Review
  8. ExtracardiacEuropean journal of nuclear medicine and molecular imaging · 2018
    Article
  9. Article
  10. Nuclear imaging of cardiac amyloidosis. 'We've only just begun'.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2018
    Article
  11. Review
  12. Role of imaging in cardiac amyloidosis: An ongoing challenge.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2016
    Article
  13. Quantitative molecular imaging of cardiac amyloidosis: The journey has begun.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2016
    Article
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Tanja KeroDepartment of Nuclear Medicine & PET, Uppsala University, Uppsala, Sweden. tanja.kero@radiol.uu.se.
Lars LindsjöDepartment of Nuclear Medicine & PET, Uppsala University, Uppsala, Sweden.
Jens SörensenDepartment of Nuclear Medicine & PET, Uppsala University, Uppsala, Sweden.
Mark LubberinkDepartment of Nuclear Medicine & PET, Uppsala University, Uppsala, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background(11)C-PIB PET is a promising non-invasive diagnostic tool for cardiac amyloidosis. Semiautomatic analysis of PET data is now available but it is not known how accurate these methods are for amyloid imaging. The aim of this study was to evaluate the feasibility of one semiautomatic software tool for analysis and visualization of (11)C-PIB left ventricular retention index (RI) in cardiac amyloidosis. METHODS AND

resultsPatients with systemic amyloidosis and cardiac involvement (n = 10) and healthy controls (n = 5) were investigated with dynamic (11)C-PIB PET. Two observers analyzed the PET studies with semiautomatic software to calculate the left ventricular RI of (11)C-PIB and to create parametric images. The mean RI at 15-25 min from the semiautomatic analysis was compared with RI based on manual analysis and showed comparable values (0.056 vs 0.054 min(-1) for amyloidosis patients and 0.024 vs 0.025 min(-1) in healthy controls; P = .78) and the correlation was excellent (r = 0.98). Inter-reader reproducibility also was excellent (intraclass correlation coefficient, ICC > 0.98). Parametric polarmaps and histograms made visual separation of amyloidosis patients and healthy controls fast and simple.

conclusionAccurate semiautomatic analysis of cardiac (11)C-PIB RI in amyloidosis patients is feasible. Parametric polarmaps and histograms make visual interpretation fast and simple.

Indexed as

AgedAmyloidosisAniline CompoundsBenzothiazolesBiomarkersFemaleHeartHeart FailureHumansImage EnhancementImage Interpretation, Computer-AssistedMaleMiddle AgedMyocardiumObserver VariationPattern Recognition, Automated2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazoleAniline CompoundsBenzothiazolesBiomarkersRadiopharmaceuticalsThiazolesAmyloidC-11 PIBcardiac amyloidosisPET imaging

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.